Durán, A.M.; Whitley, K.; Santiago, K.; Yoo, C.; Valdez, G.; Cheng, K.W.; Ochoa, P.; de Semir, D.; Xiu, J.; Chokkalingam, P.;
et al. Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel. Cancers 2025, 17, 1535.
https://doi.org/10.3390/cancers17091535
AMA Style
Durán AM, Whitley K, Santiago K, Yoo C, Valdez G, Cheng KW, Ochoa P, de Semir D, Xiu J, Chokkalingam P,
et al. Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel. Cancers. 2025; 17(9):1535.
https://doi.org/10.3390/cancers17091535
Chicago/Turabian Style
Durán, Alfonso M., Kristen Whitley, Krystal Santiago, Christian Yoo, Giancarlo Valdez, Kai Wen Cheng, Pedro Ochoa, David de Semir, Joanne Xiu, Parthiban Chokkalingam,
and et al. 2025. "Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel" Cancers 17, no. 9: 1535.
https://doi.org/10.3390/cancers17091535
APA Style
Durán, A. M., Whitley, K., Santiago, K., Yoo, C., Valdez, G., Cheng, K. W., Ochoa, P., de Semir, D., Xiu, J., Chokkalingam, P., Das, S., Schaefer, E. S., Rowe, S. P., Das, B. C., Casiano, C. A., & Almaguel, F.
(2025). Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel. Cancers, 17(9), 1535.
https://doi.org/10.3390/cancers17091535